FOLIA BIOL-PRAGUE 润色咨询

FOLIA BIOLOGICA

出版年份：1955 年文章数：791 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：1.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1090613, encodeId=bb46109061324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090614, encodeId=482c1090614a1, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542767, encodeId=c369542e67e7, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817555, encodeId=02f481e5554d, content=捷克的双月刊 生物类专业杂志，偏向于药理学，药物的信号通路<br> 档次一般 sci收录 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Thu Dec 29 11:18:00 CST 2011, time=2011-12-29, status=1, ipAttribution=)]
    2021-12-27 ms6000000264964247

    结果中的重要文献是在结果体现，还是在引言中描述？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1090613, encodeId=bb46109061324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090614, encodeId=482c1090614a1, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542767, encodeId=c369542e67e7, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817555, encodeId=02f481e5554d, content=捷克的双月刊 生物类专业杂志，偏向于药理学，药物的信号通路<br> 档次一般 sci收录 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Thu Dec 29 11:18:00 CST 2011, time=2011-12-29, status=1, ipAttribution=)]
    2021-12-27 MS68862005

    方法的撰写顺序/逻辑顺序是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1090613, encodeId=bb46109061324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090614, encodeId=482c1090614a1, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542767, encodeId=c369542e67e7, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817555, encodeId=02f481e5554d, content=捷克的双月刊 生物类专业杂志，偏向于药理学，药物的信号通路<br> 档次一般 sci收录 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Thu Dec 29 11:18:00 CST 2011, time=2011-12-29, status=1, ipAttribution=)]
    2017-07-14 weiwei_zhu

    反正就这个熊样,也不会有所变化,只要不跌,也就万幸了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1090613, encodeId=bb46109061324, content=结果中的重要文献是在结果体现，还是在引言中描述？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=85, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=1ff65466529, createdName=ms6000000264964247, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1090614, encodeId=482c1090614a1, content=方法的撰写顺序/逻辑顺序是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542767, encodeId=c369542e67e7, content=反正就这个熊样,也不会有所变化,只要不跌,也就万幸了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=228, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=weiwei_zhu, createdTime=Fri Jul 14 18:51:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=817555, encodeId=02f481e5554d, content=捷克的双月刊 生物类专业杂志，偏向于药理学，药物的信号通路<br> 档次一般 sci收录 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77f15414044, createdName=ms6596549308483070, createdTime=Thu Dec 29 11:18:00 CST 2011, time=2011-12-29, status=1, ipAttribution=)]
    2011-12-29 ms6596549308483070

    捷克的双月刊 生物类专业杂志，偏向于药理学，药物的信号通路
    档次一般 sci收录

    0

共6条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分